Angel Eye promotes bonding for your family when you are unable to visit your baby in the nursery. A high-definition camera is placed at your baby’s bedside so that you are able to view your child in real time from your computer or mobile device. If you have a computer microphone, you also have the ability to speak to your child via a one-way sound-leveled audio to strengthen bonding and provide comfort to your baby. It can be a very scary time when a baby is in intensive care, and this solution is meant to alleviate some of those fears.

Related links: 
• UT Medical center offers new technology for parents of babies in their NICU
• New technology lets families see NICU babies from afar
• Technology at Bryan Health Changes Lives for Local Family with Baby in Neonatal ICU
• Upstate hospital becomes first in SC to connect parents, babies in ICU through ‘Angel Eye’
• Baby Girl Is Born 6 Weeks Early, Then Nurse Puts A Camera In Her Incubator
• Local company donates camera system to Memorial Hospital NICU
• Mother of Two Says Angel Eye Cameras Eased Mind
• ‘Angel Eye’ cameras watch preemies at area hospitals
• ‘Angel Eye’ installed at University of Kansas Hospital
• Montco NICU takes step to ease parents’ separation anxiety
• Maimonides Medical Center Studies Effects of Angel Eye Webcams on NICU Parents
• New Neonatal-Unit camera at CCMC lets parents view their babies online.
• New cameras help mothers stay in touch with premature babies at St. Mary’s Hospital
• Cameras Let Parents See Babies in Forsyth Medical Center’s NICU
• Camera Helps Parents Watch Newborns In NICU At Novant Health
• International Biomedical To Serve as Exclusive Worldwide Distributor for NICU Camera System
• Little Rock’s Angel Eye Expands Network of NICU Cameras
• University Hospital gets NICU webcams
• Angel Eye completes installation of 10 cameras in CT Children’s NICUs
• Angel Eye Technology from AR Now in 5 States
• University Hospital gets NICU webcams

Bjönd is automated workflow, real-time decision support and behavior change software that consumers and businesses use to change outcomes and lives in any industry . . . in any situation. Bjönd is designed to enable anyone – even those with little or no technical skills – to build interactive content and automated, expert workflows for any subject.

Carrot Medical truly helps you “see better” by creating products that integrate audio and visual data to optimize clinical performance. The company provides integrated video and headset communications systems to hospital interventional laboratories (electrophysiology, cardiac cath and interventional radiology). Carrot C-View products integrate multiple modalities into a single, highly configurable display such that all critical data are present in a single visual display for the clinical team. Carrot C-Suite provides recording and streaming for real-time distance collaboration, teaching and patient record-keeping purposes. With its healthcare and technology expertise, Carrot Medical introduces the efficiencies achieved using advanced control interfaces into the patient care environment, increasing clinician efficiency and improving decision-making.

Evermind improves the lives of those who are living independently or managing a chronic disease, as well as those who provide care for them, by remotely monitoring the usage of home appliances and home medical equipment. The company is developing a passive monitoring system that alerts a primary caregiver of a possible decline in an activity of daily living (“ADL”) of the monitored individual.

Goba was founded with a passion to create technology that helps people build and maintain face-to-face relationships. The company is now taking that a step further by using their historical understanding of how to drive user engagement and packaging it in an API platform so that other enterprises can incorporate Goba’s services into their own mobile strategy and offerings. They are taking advantage of the tremendous growth of mobile technology in order to drive real-world, offline engagement, regardless of the technology platform.

MedCenterDisplay is an advanced digital communication network specifically designed to meet the needs of healthcare facilities. Their multi-functional network immediately engages patients and their families while they are waiting to see their healthcare provider. MedCenterDisplay’s application allows healthcare organizations to improve information flow to patients, staff and visitors during their time in waiting rooms, lobbies and other high-traffic areas.

Related Links:
• Latest Acquisition Deepens the PatientPoint Hospital Footprint
• Northeastern Nevada Regional Hospital, In Partnership with MedCenterDisplay, Improves Communication with Patients, Staff and Visitors through New Patient Engagement Network Installation

onFocusHealthcare We believe the future of healthcare lies in your data. By combining sophisticated analytics with the know-how to act on them, MedeAnalytics helps you see the connections—between payer and provider, cost and quality, and good business and better healthcare.

Satchel Health is a care management company that specializes in telemedicine solutions and performance strategies for post-acute care organizations.

Related Links
• How one firm’s technology could change care in assisted-living facilities – and prisons
• Satchel Health Aims to Reduce Hospital Readmissions with Modern Telemedicine Platform
• Satchel Health adds another $1.5M for its post-acute-focused telemedicine platform
• New CEO for Satchel Health
• A new vision: How this Nashville startup moved on from Google Glass
• Satchel Health gets $1M to bring connected devices, telehealth to post-acute patients

Preferral is the most advanced way to manage,customize, and analyze your patient referrals with instant appointments, reduced administrative costs and EMR agnostic.

Related Links
• Familiar face named CEO of this Nashville startup

Quire translates the rich narrative of patient encounters into useful, searchable data so you can identify rising-risk patients sooner, and take action to improve clinical and financial outcomes for your population.

Related links:
• Quire Launches Predictive Analytics Technology
• Quire Unveils Industry’s Most Dynamic Technology for Predictive Analytics in Value-Based Care

Diabetes Care Group integrates state-of-the-art medical management, patient education and behavioral modification to improve patient self-management and clinical outcomes, while reducing the overall medical and social costs of diabetes. The company’s integrated approach, built on more than ten years of research and clinical experience, has a track record of getting results for individuals with diabetes.

Cobra Introducer allows a medical professional to perform intubations with difficult anatomy without the use of expensive equipment or without learning  a significantly new technique. An unmet clinical need exists in solving the problem of introducing an intubation tube into the trachea, and this simple device makes this process simpler, more reliable and saves significant time for the anesthesiologist.

PathFinder Analogic provides leading-edge healthcare and security technology solutions to advance the practice of medicine and save lives. We are recognized around the world for advanced imaging and real-time guidance technologies used for disease diagnosis and treatment as well as for automated threat detection. Analogic is headquartered just north of Boston, Massachusetts.

TVA Medical is developing the first catheter-based system for creating an AV fistula for vascular access for dialysis. The procedure is a percutaneous, non-surgical method using one catheter in a forearm vein and one in a forearm artery. AV fistula is the gold standard for dialysis vascular access, but prior to the TVA technology, the only way to create an AV fistula was through an open surgical procedure.

Related links:
• TVA Medical Receives CE Mark For Next-Generation everlinQ™ 4 endoAVF System
• Magnetic Technology Creates Easy Endovascular Access
• Study Published In Prominent Journal Supports Use Of Innovative Endovascular Hemodialysis Access Technology
• Exciting Clinical Results Presented On Endovascular Hemodialysis Access Technology
• Early Study Results For Endovascular Hemodialysis Access System Presented In Late-Breaking Session
• TVA Medical Closes $15 Million Series C Financing.
• Novel Hemodialysis Access System Demonstrates High Suitability For Dialysis In Clinical Trial
• TVA Medical Receives Additional Reimbursement In Germany For The everlinQ™ endoAVF System

Diagnovus is a specialized molecular diagnostic company focused on delivering personalized diagnostic information and services to physicians treating patients suffering from rare, orphan and less frequent diseases. Diagnovus’ mission is to improve the health of patients and quality of treatment decisions through truly innovative molecular diagnostics by better informing physicians, patients and families that face these difficult disease prospects.

GenomOncology is enabling precision medicine by translating next generation sequencing data into actionable information for clinicians and researchers. As the bottleneck of cancer molecular diagnostics has moved from data acquisition to data interpretation, GenomOncology has developed a proprietary technology platform to streamline the use of next generation sequencing in medicine and research.

Related links:
• UCSF Enhances Cancer Assay with Interpretive Reporting Powered by GenomOncology’s GO Clinical Workbench
• GenomOncology and med fusion announce the addition of PD-L1 Testing and Interpretation to the LungSEQ® and 50SEQ® Plus FISH Tests
• GenomOncology Names Joshua F. Coleman, M.D. as New VP of Medical Affairs
• Fluidigm and GenomOncology Partner to Provide Automated Oncology NGS Library Preparation With Molecular Interpretation and Reporting
• GenomOncology Enhances the GO Clinical Workbench for Hematological Cancer Analysis and Reporting
• Updates to GenomOncology’s Platform Expand Company’s Footprint in Clinical NGS Market
• Genomics England to use GenomOncology’s Knowledge Management System to Analyze Cancer Samples in the 100,000 Genomes Project
• Pathline Emerge Launches DNA Profiling Tests using GenomOncology’s GO Clinical Workbench
• Harnessing Genomic Data: An Interview with Ben Salisbury, V.P. of GenomOncology
• Congenica and GenomOncology announce collaborative agreement at AMP
• ArcherDX and GenomOncology to Collaborate on NGS Workflow Applications
• GenomOncology appoints David Lasecki as Chief Commercialization Officer
• UCLA Health Implements Tumor DNA Profiling using GenomOncology’s GO Clinical Workbench
• Hawai’i Pathologists’ Laboratory Launches First-in-Hawaii Tumor DNA Profiling Tests using GenomOncology’s GO Precision Medicine Portfolio
• Thomas Jefferson University Hospital and GenomOncology Codeveloping Multi-assay Integrated Cancer Profiling System
• GenomOncology appoints Dr. Benjamin Salisbury as Vice President, New Products and Marketing

Molecular Sensing, Inc. is an early-stage life sciences company dedicated to commercializing a new, game-changing molecular interaction biosensor technology, Back-Scattering Interferometry (BSI). BSI addresses unmet needs in pharmaceutical drug discovery and development, biomedical research, and diagnostics by overcoming the limitations of SPR and ITC, while combining their advantages in a single, synergistic platform.

NuSirt Biopharma has discovered a breakthrough technology platform that enables the use of natural compounds to prevent and treat chronic diseases resulting from over-nutrition and aging. The company has successfully conducted multiple clinical studies on natural compounds that have validated its discovery and demonstrated the value of its intellectual property. NuSirt has also conducted pre-clinical work establishing the synergy of these compounds with known pharmaceuticals.

Related links:
• Fighting fatty liver disease: NuSirt’s Joe Cook oversees clinical trials for possible breakthrough drug
• NuSirt Biopharma and OWL Metabolomics Partner to Advance Treatment of NASH / Non-alcoholic Steatohepatitis
• NuSirt Biopharma Presenting New Research at American Diabetes Association’s 76th Annual Scientific Sessions
• NuSirt Biopharma to Present at American Diabetes Association’s 76th Scientific Sessions
• NuSirt Biopharma Plans Clinical Trial in Non-Alcoholic Fatty Liver Disease
• NuSirt Biopharma Receives FDA Fast Track Designation for Non-Alcoholic Fatty Liver Disease Treatment
• Clinical Trial Results Show Synergy between NuSirt Technology and Metformin in Patients with Type 2 Diabetes